A Controlled Multi-Arm Phase 1 Umbrella Study Evaluating the Safety and Feasibility of T-Cell Receptor Engineered Donor T-Cells Targeting HA-1 (TSC-100) or HA-2 (TSC-101) in HLA-A*02:01 Positive Patients Undergoing Haploidentical Allogeneic Peripheral Blood Stem Cell Transplantation
A Phase 2, Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Belumosudil in Black or African American Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy
A Phase Ib /Randomized Phase III Trial of Patients with Advanced Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation with Either Orca-T, a T-cell-Depleted Graft with Additional Infusion of Conventional T cells and Regulatory T cells, or Standard-of-Care Allogeneic Graft
A Phase Ib Study of oral decitabine/cedazuridine as maintenance therapy following allogeneic hematopoietic cell transplantation for patients with myeloid neoplasms
A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE 2A STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PBCLN-010 IN COMBINATION WITH PBCLN-014 IN PARTICIPANTS RECEIVING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
SHARON: Study of Metastatic Cancers in Patients With an Inherited Defect in a Homologous Recombination Gene Using Autologous Stems Cells and Potentiated Redox Cycling to Overcome Drug Resistance to Nitrogen Mustard Derivatives
